Understanding the deeper complexities of the immune system is critical to providing insights into immune based therapeutic candidates and their functioning. The IntelliCyt® iQue Screener PLUS platform is a high throughput suspension cell screening platform that facilitates simultaneous assessment of multiple parameters such as cell health and function from multiple cell types in a single well, while using minimal sample volumes. With this capability, more powerful assays can be developed to look at multiple endpoints and generate more correlative data from precious samples.
This webinar will feature two talks
- An overview of how researchers at Horizon Discovery utilize the IntelliCyt iQue Screener PLUS platform to deliver rich datasets for clients to aid compound screening, target validation and mechanism of action studies. It will highlight the benefits of utilising the iQue Screener PLUS platform over more traditional screening approaches
- Highlight of the IntelliCyt iQue Screener PLUS platform and how it is transforming immuno-oncology development with its high throughput flow-based analysis and intuitive ForeCyt® Software. A brief overview of the ForeCyt Software workflow experience and upcoming features that will impact applications in immuno-oncology.
- Simon Scrace, Ph.D.
Manager – Immunology and Assay Services, Horizon Discovery
- Joseph M. Zock
Senior Director Product Management, IntelliCyt A Sartorius Brand